Braden Michael Leonard, 10% Owner at AN2 Therapeutics, Inc. (ANTX), bought 1,500,000 shares at $1.04 ($1.6M) on 2024-08-14, disclosed to the SEC on 2024-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADVM | SELL | 2025-12-03 | $3.6M | — | Filing → |
| ASTC | SELL | 2025-10-07 | $3.2M | — | Filing → |
| ANTX | SELL | 2025-06-16 | $436K | — | Filing → |